Clinical Trials for Psoriasis

Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece

NCT ID: NCT06247319

This clinical trial is studying the effectiveness of a medication called risankizumab for people who have recently been diagnosed with moderate plaque psoriasis, a skin condition that causes red, i...

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

NCT ID: NCT07033234

This clinical trial is studying a new medicine called HS-20118 to see if it is safe and how it behaves in the body, especially for people with moderate to severe plaque psoriasis, a skin condition ...

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

NCT ID: NCT06846541

This clinical trial is studying a medication called ESK-001 to see how safe it is when taken for a long time by people with moderate to severe plaque psoriasis, a skin condition that causes red, sc...

Psorcast Mobile Study

NCT ID: NCT05621369

The Psorcast Mobile Study is a clinical trial aimed at understanding how symptoms of psoriasis and psoriatic arthritis can vary among patients. This study uses a smartphone app to make it easy for ...

Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients

NCT ID: NCT06702293

This clinical trial is looking at a new way to help people with skin conditions like eczema, psoriasis, and urticaria (hives). Researchers want to see if using a special mobile app that provides ps...

Topical SGX302 for Mild-to-Moderate Psoriasis

NCT ID: NCT05442190

This clinical trial is studying a new treatment called SGX302, which is a topical ointment made with hypericin, used alongside visible light therapy. The aim is to see if this treatment can help im...

Skin Microbial Ecology in Atopic Dermatitis

NCT ID: NCT04170244

This clinical trial is studying the skin bacteria in people with atopic dermatitis (AD) and psoriasis (PS) to understand how these bacteria change with standard treatments. Researchers want to lear...

Multi-Center PAMPA Study

NCT ID: NCT05004727

The Multi-Center PAMPA Study is a clinical trial aimed at understanding how a medication called guselkumab can help patients with psoriasis who are at high risk of developing psoriatic arthritis (P...

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT ID: NCT06857942

The TOGETHER AMPLIFY-PsO clinical trial is studying how effective a new medication called tirzepatide is when added to an existing treatment, ixekizumab, for people with moderate-to-severe plaque p...

A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

NCT ID: NCT06999941

Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

NCT ID: NCT06399432

This clinical trial is studying whether following a Mediterranean diet can help improve the signs and symptoms of psoriasis in patients who are starting treatment with specific medications called A...

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

NCT ID: NCT03816345

This clinical trial is studying how well a medication called nivolumab works for patients who have autoimmune disorders and advanced cancers that are difficult to treat or remove with surgery. Nivo...

Multi-modal Quantitative Imaging of the Skin

NCT ID: NCT06989216

This clinical trial, called "Multi-modal Quantitative Imaging of the Skin," is exploring a new imaging technology that can help screen for and detect skin-related diseases, including skin cancer, p...

Role of Insulin Action in Psoriasis Pathogenesis

NCT ID: NCT06242847

This clinical trial is focused on understanding the role of insulin in people with plaque psoriasis, a common skin condition characterized by red, scaly patches. Researchers want to find out if ins...

Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

NCT ID: NCT05111210

This clinical trial is studying how certain medications, known as anti-IL-23 biologics, work in patients with psoriasis, a skin condition that causes red, flaky patches. The goal is to learn more a...

Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis

NCT ID: NCT06735911

This clinical trial is exploring how a special spa treatment designed for skin conditions affects the quality of life for patients with psoriasis, a chronic skin condition that can cause redness, i...

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

NCT ID: NCT04751396

This clinical trial is exploring how well an educational tool can help patients with melanoma who also have existing autoimmune diseases understand their treatment options involving immune checkpoi...

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

NCT ID: NCT03661866

The TARGET-DERM study is looking at how well current and future treatments work for people with skin conditions like Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasi...

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

NCT ID: NCT06742333

This clinical trial is studying a new treatment called bimekizumab for people with plaque psoriasis, a skin condition that causes red, scaly patches. The goal is to see if this treatment can help d...

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

NCT ID: NCT06723171

This clinical trial is studying a new treatment called IRX4204 for adults with mild to moderate plaque psoriasis, a skin condition that causes red, scaly patches. The researchers want to find out i...